Top 4 HMO Stocks to Monitor Amid Rising Expenses and Nursing Shortages

Avatar photo

The U.S. health insurance industry, particularly Health Maintenance Organizations (HMOs), is undergoing significant changes driven by technological innovation and increased mergers and acquisitions (M&A). With three Federal Reserve interest rate cuts anticipated in 2025, insurers may find it easier to finance acquisitions, potentially leading to further industry consolidation. However, regulatory changes may tighten Medicaid eligibility and decrease Affordable Care Act (ACA) enrollment, impacting both membership and reimbursement rates.

Medical expenses are rising due to returning deferred care, chronic disease management, and escalating specialty drug costs. The Health Benefit Ratio, which measures insurer profitability, is under pressure, leading to tighter profit margins. The Zacks Medical-HMO industry currently ranks #224 out of 243 industries, indicating a bearish outlook amid a 35.6% decline over the past year, compared to a 24.4% increase for the S&P 500.

Key players in the HMO sector, including UnitedHealth Group, Cigna, Humana, and Centene, are adapting by expanding their product offerings and pursuing strategic acquisitions. For instance, UnitedHealth expects earnings growth of 8.3% in 2026, while Cigna anticipates a 1.5% rise. Despite these efforts, the industry faces ongoing challenges, including a nationwide healthcare professional shortage, which could affect service quality and customer retention.

The free Daily Market Overview 250k traders and investors are reading

Read Now